pharmaceutical lawyers

Tag Archive

What You Should Know About Fournier’s Gangrene

What You Should Know About Fournier’s Gangrene

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) issued a warning in late August 2018 about the link between diabetic medications and a rare, yet life-threatening disease called Fournier’s gangrene. The warning is specific to certain FDA-approved inhibitors (SGLT2), which are said to prevent the kidneys from reabsorbing sugar into the blood, therefore helping lower blood…Read the article
GET HELP NOW